Company / Free Cash Flow per Share
Revolution Medicines, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4.92
FY2025
5-year range
-$4.92 / -$0.78
FY2021-FY2025
Trend
-42.6%
vs FY2024
Sector context
#176 of 192
Health Care
What the data says
Among 192 Health Care companies, Revolution Medicines, Inc. is in the bottom 8% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 8 years, ranging from $-18.83 in FY2019 to $-0.09 in FY2020.
Based on SEC 10-K filings.
-4.92 in FY2025.
Declined from $-3.96 to $-4.92 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 192This company -$4.92 Sector average $3.32
▼
-248.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 42.6% year-over-year.
- Ranks #176 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.92 | -42.6% |
| FY2024 | -$3.45 | +13.0% |
| FY2023 | -$3.96 | -185.3% |
| FY2022 | -$1.39 | -77.2% |
| FY2021 | -$0.78 | -802.3% |
| FY2020 | -$0.09 | +99.5% |
| FY2019 | -$18.83 | -15034.4% |
| FY2018 | -$0.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026